Administrative expenses, impairment finance costs and share of loss from associates 57.53 777.43 37.52 78.22 Doubtful Account 86.50 1,168.92 - - Loss on impairment of goodwill 51.20 691.89 - - Management benefit
100.00 53.24 100.00 Costs - - 20.59 38.67 Administrative expenses, impairment finance costs and share of loss from associates 38.23 335.05 88.84 166.87 Impairment of investment in associate 29.81 261.26
sales 6.1% 7.5% (1.4%) 5.7% 7.1% (1.4%) Administrative expense per net sales 10.5% 12.5% (2.0%) 8.6% 9.8% (1.2%) Net profit margin 4.4% 3.1% 1.3% 6.7% 5.8% 0.9% Earnings per share (Bath/Share) 0.05 0.03
1,221.6 81.8% Share of Profit from Investments in Associates and JVs 491.3 693.3 202.0 41.1% Total Cost 773.7 1,248.6 474.9 61.4% Gross Profit 603.8 1,314.7 710.9 117.7% Net Profit 334.5 972.4 637.9 190.7
% (15,696) 113.17% Share of profit from investment in associate 2,436 0.24% 719 0.08% 1,717 238.80% Profit (loss) before income tax income (expenses) 120,118 12.03% 98,812 11.66% 21,306 21.56% Income tax
. II) The rights and equitable treatment of shareholders and key ownership functions; The chapter identifies basic shareholder rights, including the right to information and participation through the
= Translation = Management Discussion and Analysis for Interim Business Operations The Information of Share Capital Registration and Entire Business Transfer The Company registered the change of
water, wastewater treatment and hydrogen and supplies its utilities to the Artlant PTA plant. PTA is a core strategic business of IVL and we are confident that over time the Portugal PTA plant will
subsidiary for Quarter 1 of 2019 ending on 31 March 2019 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical treatment for the 1st
suppliers. The plant now has been completed but still in the process of mechanical testing and improving the treatment formula. For the RDF facility in the second quarter, the Company has started to adjust